TCTR20201217003Unknown不适用
Quantitative G6PD diagnostics followed by treatment decision for vivax malaria: how do village malaria workers perform?
Joint Global Health Trials MRC0 个研究点目标入组 2,590 人开始时间: 2020年12月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 2,590
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •1.Participant is willing and able to give informed consent for participation in the study.
- •2.Male or female, aged 18 years or above.
- •3.Healthy volunteers (VMWs or lab technicians), febrile patients or vivax malaria patients who are willing to participate in the study.
排除标准
- •1.Healthy participants (VMWs or lab technicians) or febrile patients or vivax malaria patients who are suffering from severe disease or condition such that testing on them may add burden to them.
- •2.Patients who are not willing to travel to/follow up at the local health centre for radical cure treatment.
- •3.Patients or healthy participants who fear blood or needles.
研究者
相似试验
已完成
不适用
Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in BrazilG6PD DeficiencyNCT04033640PATH1,754
已完成
不适用
Validation of New G6PD Point of Care Tests Against Gold Standard QuantitativeValidationBiosensorsGenotypingNCT02625285University of Oxford150
尚未招募
Unknown
treating pathological cases with homoeopathy using repertory.CTRI/2024/05/068007Rajkot Homoeopathic Medical College, Parul University.
进行中（未招募）
1 期
Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT instudy of neuroblastoma: comparison with 123I-MIBG scintigraphypatients wiht NB onset with high probability to return in stages 3 and 4 of the disease on the basis of the ultrasound images or TC. May also be included with the two-stage amplification of N-MYCMedDRA version: 14.1Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-005398-30-ITAZIENDA OSPEDALIERA OSPEDALI GALLIERA40
已完成
4 期
Results of Glucose-6-phosphate Dehydrogenase Deficiency Screening Relate with Cost of Phototherapy in Neonatal Hyperbilirubinemia; A Randomized Controlled TrialGlucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) is one of risk factors that should decrease the phototherapy threshold to be lower than G6PD-normal neonates.hyperbilirubinemia, phototherapy, G6PD deficiency, neonate, screeningTCTR20220705006/A241